New eye drop aims to ease pain of retinal shots
Symptom relief
Not yet recruiting
This study tests a new eye drop called IRX-101 to see if it reduces pain and surface damage after anti-VEGF injections for retinal disease. About 240 adults who get these injections will receive either IRX-101 or standard povidone-iodine. The goal is to make the procedure more co…
Phase: PHASE3 • Sponsor: iRenix Medical, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC